Peripheral oxytocin treatment modulates central dopamine transmission in the mouse limbic structures

https://doi.org/10.1016/0197-0186(86)90138-5Get rights and content

Abstract

The effects of subcutaneous (s.c.) oxytocin treatment have been investigated on various parameters of dopaminergic neurotransmission in basal forebrain structures (nucleus olfactorius posterior + nucleus accumbens + septum) of the mouse. Acute oxytocin treatment failed to influence dopamine utilization in the basal forebrain. Following chronic injections of oxytocin (0.2 mg/kg) for 8 8 days, the neuropeptide decreased dopamine utilization. Neither in vivo nor in vitro oxytocin treatment was capable of influencing the in vitro uptake of [3H]dopamine in basal forebrain slices. The spontaneous release of [3H]dopamine (in the presence of 4.2 mM K+) from basal forebrain tissue slices was not affected by in vitro or acute or chronic in vivo oxytocin treatment. The stimulated release of [3H]dopamine (in the presence of 30 mM K+) was significantly inhibited by chronic in vivo oxytocin administration. Chronic oxytocin treatment decreased the Bmax value of [3H]spiroperidol binding in the basal forebrain. The dissociation constant (Kd) of [3H]spiroperidol binding was not influenced by oxytocin. The data indicate that peripheral oxytocin treatment is capable of modifying dopaminergic neurotransmission in mouse basal forebrain regions.

Cited by (25)

  • Reversal of oxycodone conditioned place preference by oxytocin: Promoting global DNA methylation in the hippocampus

    2019, Neuropharmacology
    Citation Excerpt :

    These paradoxical effects of OT might be related to the direct actions of OT stimulation on the dopaminergic system. Kovács et al. (1990) showed that both peripheral and central administration of OT acutely increased dopamine utilization within the Acb, while chronic systemin administration of OT decreased dopamine utilization with the basal forebrain of mice (Kovács et al., 1986). However, the choice of OT paradigm and dose seems to be critical in determining the beneficial effects of the drug.

  • Oxytocin prevents the increase of cocaine-related responses produced by social defeat

    2019, Neuropharmacology
    Citation Excerpt :

    It has been hypothesized that there is an association between the oxytocinergic and dopaminergic systems by which they regulate motivational behaviors (Zanos et al., 2014). Central or peripheral administration of OXT acutely increases DA utilization within the NAc, while chronic administration of OXT decreases DA utilization within the basal forebrain of mice (Kovàcs et al., 1986, 1990). In addition, there is strong evidence that OXT plays a role in the rewarding effects of drugs of abuse.

  • Opioid addiction: Who are your real friends?

    2017, Neuroscience and Biobehavioral Reviews
    Citation Excerpt :

    These results are reviewed thoroughly by McGregor and Bowen (2012) and Kovács et al. (1998). It has been demonstrated since at least the mid-1980s that increasing oxytocin in the brain dampens heroin reward and decreases self-administration (Kovacs et al., 1985a; Kovacs et al., 1986). Conversely, morphine exposure alters brain levels of oxytocin (Kovacs et al., 1985b; You et al., 2000), indicating a bidirectional interaction between these systems.

  • Neuropeptides as neuroprotective agents: Oxytocin a forefront developmental player in the mammalian brain

    2014, Progress in Neurobiology
    Citation Excerpt :

    Licking and grooming upregulates estrogen synthesis in the brain through a pathway to be studied (Caba et al., 2003; Westberry et al., 2010). Several lines of evidence point toward the involvement of gastrointestinal and cardiovascular hormone peptides such as: CCK, gastrin, VIP and OT (Gainer et al., 2002; Jankowski et al., 2004; Morton et al., 2006; Vickers et al., 2008; Welch et al., 2009), NGF, BDNF, and cytokines (Raison et al., 2006; Sofroniew et al., 2001) in neonatal offsprings, acting through vagal, sciatic and perineal sensory afferents (Feng et al., 2009; Huang and Reichardt, 2001; Gutkowska and Jankowski, 2012; Lenz and Sengelaub, 2009; Uvnäs-Moberg and Petersson, 2005) that activate caudal brain stem noradrenergic (Onaka et al., 1995) and mesolimbic dopaminergic activity (Liu and Wang, 2003; Kovacs et al., 1986; Stern and Keer, 1999), inducing steroidogenesis synthesis by neuronal and testicular cells in the neonatal rat (Agis-Balboa et al., 2006; Gerendai and Csernus, 1995). This sensorial stimulation induces the expression of many different proteins throughout the brain which are known to regulate and mediate neuronal plasticity (Chatterjee et al., 2007; Gao and Horvath, 2007; Huang and Reichardt, 2001; Kennedy and Ehlers, 2006).

  • Oxytocin and object preferences in the male prairie vole

    2014, Peptides
    Citation Excerpt :

    Because OT was administered peripherally, it is not possible to conclude that the apparent behavioral differences between OT and the control treatment (SAL) are direct actions on the brain. There is increasing evidence under other conditions that peripherally-administered OT can have behavioral consequences in human and non-human animals [23,25,27]. However, OT only weakly crosses the blood brain barrier (BBB).

  • Gestational ethanol and nicotine exposure: Effects on maternal behavior, oxytocin, and offspring ethanol intake in the rat

    2008, Neurotoxicology and Teratology
    Citation Excerpt :

    Oxytocin pretreatment can attenuate dopamine utilization in the nucleus accumbens in response to cocaine [6]. Chronic oxytocin injections are also able to inhibit the stimulated release of dopamine in the basal forebrain [33]. It is possible that oxytocin receptor activation may be interfering with D2 receptors in the VTA, potentially leading to fewer incidences of burst firing within VTA projections to the nucleus accumbens, which have been shown to play an important role in the development of addiction [55].

View all citing articles on Scopus
View full text